ConductScience.org, home

Paper37849802

The stratification and prognostic importance of molecular and immune landscapes in clear cell renal cell carcinoma.

Zhai X and 6 others. Front Oncol, 2023. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. The stratification and prognostic importance of molecular and immune landscapes in clear cell renal cell carcinoma. Papers, record 37849802. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37849802

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The stratification and prognostic importance of molecular and immune landscapes in clear cell renal cell carcinoma.
PubMed
Journal
Front Oncol
PubMed
Year
2023
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Relative citation ratio, by iCite
0
iCite
Revised in PubMed
2023-10-20
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zhai XXinyu
2Chen XXinglin
3Gu JJianyi
4Guo DDongdong
5Zhan XXiangyang
6Tan MMingyue
7Xu DDongliang

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References18

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
135326557Angiogenesis Inhibitors and Immunomodulation in Renal Cell Cancers: The Past, Present, and Future.Cancers (Basel)2022https://conductscience.org/library/papers/35326557PubMed
230672334Clear Cell Papillary Renal Cell Carcinoma.Arch Pathol Lab Med2019https://conductscience.org/library/papers/30672334PubMed
330799404Non-Clear Cell Renal Cell Carcinoma - Pathology and Treatment Options.Oncol Res Treat2019https://conductscience.org/library/papers/30799404PubMed
432251007Report From the International Society of Urological Pathology (ISUP) Consultation Conference on Molecular Pathology of Urogenital Cancers: III: Molecular Pathology of Kidney Cancer.Am J Surg Pathol2020https://conductscience.org/library/papers/32251007PubMed
531278395The Cancer Genome Atlas of renal cell carcinoma: findings and clinical implications.Nat Rev Urol2019https://conductscience.org/library/papers/31278395PubMed
629967214Resistance to Systemic Therapies in Clear Cell Renal Cell Carcinoma: Mechanisms and Management Strategies.Mol Cancer Ther2018https://conductscience.org/library/papers/29967214PubMed
734991918Genomics of Clear-cell Renal Cell Carcinoma: A Systematic Review and Meta-analysis.Eur Urol2022https://conductscience.org/library/papers/34991918PubMed
835203461The Frontline Immunotherapy-Based Treatment of Advanced Clear Cell Renal Cell Carcinoma: Current Evidence and Clinical Perspective.Biomedicines2022https://conductscience.org/library/papers/35203461PubMed
933818540A challenging frontier - the genomics and therapeutics of nonclear cell renal cell carcinoma.Curr Opin Oncol2021https://conductscience.org/library/papers/33818540PubMed
1036230613Identification and Validation of a Novel Ferroptotic Prognostic Genes-Based Signature of Clear Cell Renal Cell Carcinoma.Cancers (Basel)2022https://conductscience.org/library/papers/36230613PubMed
1134439293Clearing up Clear Cell: Clarifying the Immuno-Oncology Treatment Landscape for Metastatic Clear Cell RCC.Cancers (Basel)2021https://conductscience.org/library/papers/34439293PubMed
1236816976The role of immunotherapy in non-clear cell renal cell carcinoma.Front Oncol2023https://conductscience.org/library/papers/36816976PubMed
1333753250Comprehensive review of chromophobe renal cell carcinoma.Crit Rev Oncol Hematol2021https://conductscience.org/library/papers/33753250PubMed
1434359554Immune Checkpoint Inhibition in Advanced Non-Clear Cell Renal Cell Carcinoma: Leveraging Success from Clear Cell Histology into New Opportunities.Cancers (Basel)2021https://conductscience.org/library/papers/34359554PubMed
1534527080New approaches to first-line treatment of advanced renal cell carcinoma.Ther Adv Med Oncol2021https://conductscience.org/library/papers/34527080PubMed
1628276433Renal cell carcinoma.Nat Rev Dis Primers2017https://conductscience.org/library/papers/28276433PubMed
1732733094The immunology of renal cell carcinoma.Nat Rev Nephrol2020https://conductscience.org/library/papers/32733094PubMed
1833536782Expression and Role of Dickkopf-1 (Dkk1) in Tumors: From the Cells to the Patients.Cancer Manag Res2021https://conductscience.org/library/papers/33536782PubMed

Download CSV of references

Genes46

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
AGTR1185PubTator's text mininghttps://conductscience.org/library/genes/185NCBI Gene
ANXA5308PubTator's text mininghttps://conductscience.org/library/genes/308NCBI Gene
BAP18314PubTator's text mininghttps://conductscience.org/library/genes/8314NCBI Gene
CD27429126PubTator's text mininghttps://conductscience.org/library/genes/29126NCBI Gene
CD27680381PubTator's text mininghttps://conductscience.org/library/genes/80381NCBI Gene
CD40958PubTator's text mininghttps://conductscience.org/library/genes/958NCBI Gene
CD86942PubTator's text mininghttps://conductscience.org/library/genes/942NCBI Gene
CD8A925PubTator's text mininghttps://conductscience.org/library/genes/925NCBI Gene
CSMD3114788PubTator's text mininghttps://conductscience.org/library/genes/114788NCBI Gene
CTLA41493PubTator's text mininghttps://conductscience.org/library/genes/1493NCBI Gene
CTNNB11499PubTator's text mininghttps://conductscience.org/library/genes/1499NCBI Gene
DKK122943PubTator's text mininghttps://conductscience.org/library/genes/22943NCBI Gene
DKK227123PubTator's text mininghttps://conductscience.org/library/genes/27123NCBI Gene
DKK327122PubTator's text mininghttps://conductscience.org/library/genes/27122NCBI Gene
DKK427121PubTator's text mininghttps://conductscience.org/library/genes/27121NCBI Gene
DNAH91770PubTator's text mininghttps://conductscience.org/library/genes/1770NCBI Gene
FDCSP260436PubTator's text mininghttps://conductscience.org/library/genes/260436NCBI Gene
GLS227165PubTator's text mininghttps://conductscience.org/library/genes/27165NCBI Gene
GYG28908PubTator's text mininghttps://conductscience.org/library/genes/8908NCBI Gene
HAMP57817PubTator's text mininghttps://conductscience.org/library/genes/57817NCBI Gene

See all 46 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/37849802

GET https://conductscience.org/api/papers/v1/37849802/genes?page=2